Novartis Loses Bid To Toss $2.6M Zometa Award

Law360, New York (January 5, 2011, 3:13 PM EST) -- Montana's highest court has upheld a $2.6 million judgment against Novartis Pharmaceuticals Corp. in a lawsuit brought by a woman who alleged she developed a painful jaw condition after taking the company's Zometa drug.

The Supreme Court of the State of Montana rejected Novartis' request for a new trial on Dec. 30. The plaintiff, Peggy L. Stevens, developed osteonecrosis of the jaw — a condition resulting in the death of the jawbone — after being given Zometa, which was supposed to increase bone strength in cancer...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.